Henric Bjarke

Jobs 0% verified

Chief Executive Officer

Tenpoint Therapeutics Ltd

Oct 2024 - Current (1 year 9 months)
Vice President Global Metabolic Disorders Franchise

Alexion Pharmaceuticals Inc

Nov 2012 - Aug 2015 (2 years 10 months)

Henric Bjarke is Vice President, Global Metabolic Diseases Franchise. In this role he is responsible for the commercialization of asfotase alfa for the treatment of Hypophosphatasia and ALXN 1101 treating Molybdenum Cofactor Deficiency Type A. Henric joined Alexion in September 2010 to lead commercial operations in the US and Canada, expanding the efforts for Soliris in PNH and launching Soliris for aHUS. He managed the US Sales Team, US Diagnostics Group (Clinical Specialists, Diagnostic Lab Specialists, National Oncology Networks), the US OneSource Team (Case Management, Customer Operations), and the Canadian Operation based in Toronto. Alexion is a biopharmaceutical company focused on serving patients with severe and rare disorders throu
Chief Executive Officer

ACM Biosciences AG

Jun 2023 - Oct 2024 (1 year 5 months)

Stealth startup
VP North America Commercial Operations

Alexion Pharmaceuticals

Sep 2010 - Nov 2012 (2 years 3 months)
Chief Operating Officer

Inozyme Pharma

Jul 2017 - Jun 2023 (6 years)
Chief Commercial Officer

Iveric Bio An Astellas Company

Aug 2015 - Apr 2017 (1 year 9 months)

We are a biopharmaceutical company specializing in the development of novel therapeutics to treat diseases of the back of the eye, with a focus on developing therapeutics for age-related macular degeneration (AMD).
A

VP Marketing

Actavis plc now Allergan

Nov 2008 - Sep 2010 (1 year 11 months)

VP Marketing for Urology and Specialty brand portfolio
O

Vice President Sales and Marketing

OSI Eyetech

Jul 2003 - Aug 2008 (5 years 2 months)

Head of Sales and Marketing
Marketing

Pfizer

Mar 1993 - Jul 2003 (10 years 5 months)

Education 0% verified

About

Detail

Timeline

Résumé